Advertisement
AMED vs ENSG
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMED is a StrongBuy and ENSG is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMED’s FA Score shows that 0 FA rating(s) are green whileENSG’s FA Score has 1 green FA rating(s).
- AMED’s FA Score: 0 green, 5 red.
- ENSG’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMED’s TA Score shows that 4 TA indicator(s) are bullish while ENSG’s TA Score has 4 bullish TA indicator(s).
- AMED’s TA Score: 4 bullish, 4 bearish.
- ENSG’s TA Score: 4 bullish, 5 bearish.
Price Growth
AMED (@Medical/Nursing Services) experienced а +0.49% price change this week, while ENSG (@Medical/Nursing Services) price change was -0.12% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.56%. For the same industry, the average monthly price growth was +2.53%, and the average quarterly price growth was +8.85%.
Reported Earning Dates
AMED is expected to report earnings on Jul 23, 2025.
ENSG is expected to report earnings on Jul 24, 2025.
Industries' Descriptions
@Medical/Nursing Services (+1.56% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| AMED | ENSG | AMED / ENSG | |
| Capitalization | 3.02B | 7.05B | 43% |
| EBITDA | 129M | 353M | 37% |
| Gain YTD | 7.875 | 15.478 | 51% |
| P/E Ratio | 1170.50 | 33.94 | 3,449% |
| Revenue | 2.24B | 3.73B | 60% |
| Total Cash | 126M | 527M | 24% |
| Total Debt | 487M | 1.87B | 26% |
AMED | ENSG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 27 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 74 Overvalued | 81 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 8 | |
SMR RATING 1..100 | 76 | 50 | |
PRICE GROWTH RATING 1..100 | 50 | 44 | |
P/E GROWTH RATING 1..100 | 50 | 66 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMED's Valuation (74) in the Medical Or Nursing Services industry is in the same range as ENSG (81). This means that AMED’s stock grew similarly to ENSG’s over the last 12 months.
ENSG's Profit vs Risk Rating (8) in the Medical Or Nursing Services industry is significantly better than the same rating for AMED (100). This means that ENSG’s stock grew significantly faster than AMED’s over the last 12 months.
ENSG's SMR Rating (50) in the Medical Or Nursing Services industry is in the same range as AMED (76). This means that ENSG’s stock grew similarly to AMED’s over the last 12 months.
ENSG's Price Growth Rating (44) in the Medical Or Nursing Services industry is in the same range as AMED (50). This means that ENSG’s stock grew similarly to AMED’s over the last 12 months.
AMED's P/E Growth Rating (50) in the Medical Or Nursing Services industry is in the same range as ENSG (66). This means that AMED’s stock grew similarly to ENSG’s over the last 12 months.
| AMED | ENSG | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 47% | 4 days ago 70% |
| Stochastic ODDS (%) | 4 days ago 54% | 4 days ago 57% |
| Momentum ODDS (%) | 4 days ago 42% | 4 days ago 68% |
| MACD ODDS (%) | 4 days ago 40% | 4 days ago 48% |
| TrendWeek ODDS (%) | 4 days ago 47% | 4 days ago 61% |
| TrendMonth ODDS (%) | 4 days ago 38% | 4 days ago 69% |
| Advances ODDS (%) | 13 days ago 50% | 13 days ago 71% |
| Declines ODDS (%) | 4 days ago 57% | 8 days ago 58% |
| BollingerBands ODDS (%) | 4 days ago 50% | 4 days ago 58% |
| Aroon ODDS (%) | 4 days ago 30% | 4 days ago 70% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NECCX | 14.02 | 0.11 | +0.79% |
| Natixis US Equity Opportunities C | |||
| HLEMX | 40.28 | 0.24 | +0.60% |
| Harding Loevner Emerging Markets Advisor | |||
| LAMSX | 23.75 | 0.08 | +0.34% |
| Lord Abbett Dividend Growth R4 | |||
| ASMOX | 19.76 | 0.03 | +0.15% |
| AQR Small Cap Momentum Style I | |||
| URNM | 47.11 | -0.67 | -1.40% |
| Sprott Uranium Miners ETF | |||
AMED and
Correlation & Price change
A.I.dvisor tells us that AMED and ENSG have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and ENSG's prices will move in lockstep.
| Ticker / NAME | Correlation To AMED | 1D Price Change % | ||
|---|---|---|---|---|
| AMED | 100% | -0.09% | ||
| ENSG - AMED | 25% Poorly correlated | -0.29% | ||
| TALK - AMED | 24% Poorly correlated | +0.73% | ||
| OPCH - AMED | 23% Poorly correlated | +0.78% | ||
| BKD - AMED | 22% Poorly correlated | -1.43% | ||
| MD - AMED | 21% Poorly correlated | +2.93% | ||
More | ||||
ENSG and
Correlation & Price change
A.I.dvisor indicates that over the last year, ENSG has been loosely correlated with UHS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSG jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To ENSG | 1D Price Change % | ||
|---|---|---|---|---|
| ENSG | 100% | -0.29% | ||
| UHS - ENSG | 53% Loosely correlated | +0.37% | ||
| THC - ENSG | 51% Loosely correlated | +0.62% | ||
| HCA - ENSG | 49% Loosely correlated | +0.43% | ||
| PNTG - ENSG | 49% Loosely correlated | +2.44% | ||
| EHC - ENSG | 49% Loosely correlated | +0.54% | ||
More | ||||